Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells

Background: Nitric oxide (NO) has been largely associated with cardiovascular protection through improvement of endothelial function. Recently, new evidence about modulation of NO release by microRNAs (miRs) has been reported, which could be involved with statin-dependent pleiotropic effects, includ...

Full description

Bibliographic Details
Main Authors: Alvaro Cerda, Cristina Moreno Fajardo, Rodrigo Gouveia Basso, Mario Hiroyuki Hirata, Rosario Dominguez Crespo Hirata
Format: Article
Language:English
Published: Sociedade Brasileira de Cardiologia (SBC) 2015-03-01
Series:Arquivos Brasileiros de Cardiologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2015000300004&lng=en&tlng=en
_version_ 1811210108137373696
author Alvaro Cerda
Cristina Moreno Fajardo
Rodrigo Gouveia Basso
Mario Hiroyuki Hirata
Rosario Dominguez Crespo Hirata
author_facet Alvaro Cerda
Cristina Moreno Fajardo
Rodrigo Gouveia Basso
Mario Hiroyuki Hirata
Rosario Dominguez Crespo Hirata
author_sort Alvaro Cerda
collection DOAJ
description Background: Nitric oxide (NO) has been largely associated with cardiovascular protection through improvement of endothelial function. Recently, new evidence about modulation of NO release by microRNAs (miRs) has been reported, which could be involved with statin-dependent pleiotropic effects, including anti-inflammatory properties related to vascular endothelium function. Objective: To evaluate the effects of cholesterol-lowering drugs including the inhibitors of cholesterol synthesis, atorvastatin and simvastatin, and the inhibitor of cholesterol absorption ezetimibe on NO release, NOS3 mRNA expression and miRs potentially involved in NO bioavailability. Methods: Human umbilical vein endothelial cells (HUVEC) were exposed to atorvastatin, simvastatin or ezetimibe (0 to 5.0 μM). Cells were submitted to total RNA extraction and relative quantification of NOS3 mRNA and miRs -221, -222 and -1303 by qPCR. NO release was measured in supernatants by ozone-chemiluminescence. Results: Both statins increased NO levels and NOS3 mRNA expression but no influence was observed for ezetimibe treatment. Atorvastatin, simvastatin and ezetimibe down-regulated the expression of miR-221, whereas miR-222 was reduced only after the atorvastatin treatment. The magnitude of the reduction of miR-221 and miR-222 after treatment with statins correlated with the increment in NOS3 mRNA levels. No influence was observed on the miR-1303 expression after treatments. Conclusion: NO release in endothelial cells is increased by statins but not by the inhibitor of cholesterol absorption, ezetimibe. Our results provide new evidence about the participation of regulatory miRs 221/222 on NO release induction mediated by statins. Although ezetimibe did not modulate NO levels, the down-regulation of miR-221 could involve potential effects on endothelial function.
first_indexed 2024-04-12T04:49:27Z
format Article
id doaj.art-d6632e4558154528a93a1d742676cef0
institution Directory Open Access Journal
issn 1678-4170
language English
last_indexed 2024-04-12T04:49:27Z
publishDate 2015-03-01
publisher Sociedade Brasileira de Cardiologia (SBC)
record_format Article
series Arquivos Brasileiros de Cardiologia
spelling doaj.art-d6632e4558154528a93a1d742676cef02022-12-22T03:47:21ZengSociedade Brasileira de Cardiologia (SBC)Arquivos Brasileiros de Cardiologia1678-41702015-03-01104319520110.5935/abc.20140192S0066-782X2015000300004Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial CellsAlvaro CerdaCristina Moreno FajardoRodrigo Gouveia BassoMario Hiroyuki HirataRosario Dominguez Crespo HirataBackground: Nitric oxide (NO) has been largely associated with cardiovascular protection through improvement of endothelial function. Recently, new evidence about modulation of NO release by microRNAs (miRs) has been reported, which could be involved with statin-dependent pleiotropic effects, including anti-inflammatory properties related to vascular endothelium function. Objective: To evaluate the effects of cholesterol-lowering drugs including the inhibitors of cholesterol synthesis, atorvastatin and simvastatin, and the inhibitor of cholesterol absorption ezetimibe on NO release, NOS3 mRNA expression and miRs potentially involved in NO bioavailability. Methods: Human umbilical vein endothelial cells (HUVEC) were exposed to atorvastatin, simvastatin or ezetimibe (0 to 5.0 μM). Cells were submitted to total RNA extraction and relative quantification of NOS3 mRNA and miRs -221, -222 and -1303 by qPCR. NO release was measured in supernatants by ozone-chemiluminescence. Results: Both statins increased NO levels and NOS3 mRNA expression but no influence was observed for ezetimibe treatment. Atorvastatin, simvastatin and ezetimibe down-regulated the expression of miR-221, whereas miR-222 was reduced only after the atorvastatin treatment. The magnitude of the reduction of miR-221 and miR-222 after treatment with statins correlated with the increment in NOS3 mRNA levels. No influence was observed on the miR-1303 expression after treatments. Conclusion: NO release in endothelial cells is increased by statins but not by the inhibitor of cholesterol absorption, ezetimibe. Our results provide new evidence about the participation of regulatory miRs 221/222 on NO release induction mediated by statins. Although ezetimibe did not modulate NO levels, the down-regulation of miR-221 could involve potential effects on endothelial function.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2015000300004&lng=en&tlng=enÓxido NítricoColesterolInibidores de Hidroximetilglutaril-CoA RedutasesCélulas EndoteliaismicroRNAs
spellingShingle Alvaro Cerda
Cristina Moreno Fajardo
Rodrigo Gouveia Basso
Mario Hiroyuki Hirata
Rosario Dominguez Crespo Hirata
Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
Arquivos Brasileiros de Cardiologia
Óxido Nítrico
Colesterol
Inibidores de Hidroximetilglutaril-CoA Redutases
Células Endoteliais
microRNAs
title Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
title_full Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
title_fullStr Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
title_full_unstemmed Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
title_short Role of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
title_sort role of micrornas 221 222 on statin induced nitric oxide release in human endothelial cells
topic Óxido Nítrico
Colesterol
Inibidores de Hidroximetilglutaril-CoA Redutases
Células Endoteliais
microRNAs
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2015000300004&lng=en&tlng=en
work_keys_str_mv AT alvarocerda roleofmicrornas221222onstatininducednitricoxidereleaseinhumanendothelialcells
AT cristinamorenofajardo roleofmicrornas221222onstatininducednitricoxidereleaseinhumanendothelialcells
AT rodrigogouveiabasso roleofmicrornas221222onstatininducednitricoxidereleaseinhumanendothelialcells
AT mariohiroyukihirata roleofmicrornas221222onstatininducednitricoxidereleaseinhumanendothelialcells
AT rosariodominguezcrespohirata roleofmicrornas221222onstatininducednitricoxidereleaseinhumanendothelialcells